Patient satisfaction with methadone maintenance treatment in Vietnam: A comparison of different integrative-service delivery models

PLoS ONE

Volumn 10, Issue 11, 2015, Pages

  Tran, Bach Xuan ^b   Nguyen, Long Hoang ^a,c   Phan, Huong Thu Thi ^d   Latkin, Carl A ^b  

^a HANOI MEDICAL UNIVERSITY   (Viet Nam)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c VIETNAM NATIONAL UNIVERSITY   (Viet Nam)

^d MINISTRY OF HEALTH   (Viet Nam)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL TRIAL; HEALTH CARE DELIVERY; HUMAN; METHADONE TREATMENT; MODEL; PATIENT SATISFACTION; VIET NAM; ADULT; COMPARATIVE STUDY; COMPLICATION; CROSS-SECTIONAL STUDY; DRUG USE; FEMALE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTEGRATED HEALTH CARE SYSTEM; MALE; OPIATE SUBSTITUTION TREATMENT; OUTPATIENT DEPARTMENT; PROCEDURES; PSYCHOLOGY; SUBSTANCE-RELATED DISORDERS;

METHADONE;

ADULT; AMBULATORY CARE FACILITIES; CROSS-SECTIONAL STUDIES; DELIVERY OF HEALTH CARE, INTEGRATED; DRUG USERS; FEMALE; HIV INFECTIONS; HUMANS; MALE; METHADONE; OPIATE SUBSTITUTION TREATMENT; PATIENT SATISFACTION; SUBSTANCE-RELATED DISORDERS; VIETNAM;

EID: 84954062286     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0142644     Document Type: Article

References (47)

1. Tran BX, Nguyen LH, Phan HT, Nguyen LK, Latkin CA. Preference of methadone maintenance patients for the integrative and decentralized service delivery models in Vietnam. Harm reduction journal. 2015; 12(1):29. Epub 2015/09/18. doi: 10.1186/s12954-015-0063-0
2. Tran BX, Ohinmaa A, Duong AT, Nguyen LT, Vu PX, Mills S, et al. Cost-effectiveness of integrating methadone maintenance and antiretroviral treatment for HIV-positive drug users in Vietnam's injectiondriven HIV epidemics. Drug and alcohol dependence. 2012; 125(3):260-6. Epub 2012/03/23. doi: 10. 1016/j.drugalcdep.2012.02.021 .
3. Tran BX, Ohinmaa A, Duong AT, Nguyen LT, Vu PX, Mills S, et al. The cost-effectiveness and budget impact of Vietnam's methadone maintenance treatment programme in HIV prevention and treatment among injection drug users. Global public health. 2012; 7(10):1080-94. Epub 2012/10/31. doi: 10. 1080/17441692.2012.736259 .
4. Tran BX, Ohinmaa A, Duong AT, Do NT, Nguyen LT, Nguyen QC, et al. Changes in drug use are associated with health-related quality of life improvements among methadone maintenance patients with HIV/AIDS. Qual Life Res. 2012; 21(4):613-23. Epub 2011/07/07. doi: 10.1007/s11136-011-9963-y .
5. Zhang L, Celentano DD, Le Minh N, Latkin CA, Mehta SH, Frangakis C, et al. Prevalence and correlates of HCV monoinfection and HIV and HCV coinfection among persons who inject drugs in Vietnam. European journal of gastroenterology & hepatology. 2015; 27(5):550-6. Epub 2015/03/15. doi: 10. 1097/MEG.0000000000000321
6. Tran BX. Willingness to pay for methadone maintenance treatment in Vietnamese epicentres of injection- drug-driven HIV infection. Bulletin of the World Health Organization. 2013; 91(7):475-82. Epub 2013/07/05. doi: 10.2471/BLT.12.115147
7. Tran BX, Ohinmaa A, Mills S, Duong AT, Nguyen LT, Jacobs P, et al. Multilevel predictors of concurrent opioid use during methadone maintenance treatment among drug users with HIV/AIDS. PloS one. 2012; 7(12):e51569. Epub 2012/12/20. doi: 10.1371/journal.pone.0051569
8. Decision 1001/QD-TTg on National Strategy on Drug Control, (2011).
9. Tran BX, Ohinmaa A, Duong AT, Do NT, Nguyen LT, Mills S, et al. Cost-effectiveness of methadone maintenance treatment for HIV-positive drug users in Vietnam. AIDS Care. 2012; 24(3):283-90. Epub 2011/09/23. doi: 10.1080/09540121.2011.608420 .
10. Control VAoHA. The annual review of HIV/AIDS control and prevention in the first six months 2015 and action plan in the last six months in 2015. Hanoi: Ministry of Health, 2014.
11. Smith PC, Mossialos E, Papanicolas I. Performance measurement for health system improvement: experiences, challenges and prospects. Copenhagen, Denmark: World Health Organization, 2008.
12. Simpson DD, Joe GW, Rowan-Szal GA, Greener JM. Drug abuse treatment process components that improve retention. Journal of substance abuse treatment. 1997; 14(6):565-72. Epub 1998/01/23. .
13. Zhang Z, Gerstein DR, Friedmann PD. Patient Satisfaction and Sustained Outcomes of Drug Abuse Treatment. Journal of health psychology. 2008; 13(3):388-400. doi: 10.1177/1359105307088142
14. McLellan AT, Woody GE, Metzger D, McKay J, Durrell J, Alterman AI, et al. Evaluating the effectiveness of addiction treatments: reasonable expectations, appropriate comparisons. The Milbank quarterly. 1996; 74(1):51-85. Epub 1996/01/01.
15. Kelly SM, O'Grady KE, Brown BS, Mitchell SG, Schwartz RP. The role of patient satisfaction in methadone treatment. Am J Drug Alcohol Abuse. 2010; 36(3):150-4. Epub 2010/05/15. doi: 10.3109/ 00952991003736371
16. Trujols J, Garijo I, Sinol N, del Pozo J, Portella MJ, Perez de los Cobos J. Patient satisfaction with methadone maintenance treatment: the relevance of participation in treatment and social functioning. Drug and alcohol dependence. 2012; 123(1-3):41-7. doi: 10.1016/j.drugalcdep.2011.10.014.
17. Perez de los Cobos J, Fidel G, Escuder G, Haro G, Sanchez N, Pascual C, et al. A satisfaction survey of opioid-dependent clients at methadone treatment centres in Spain. Drug Alcohol Depend. 2004; 73 (3):307-13. Epub 2004/03/24. doi: 10.1016/j.drugalcdep.2003.11.001.
18. Aziz Z, Chong NJ. A satisfaction survey of opioid-dependent patients with methadone maintenance treatment. Journal of substance abuse treatment. 2015; 53:47-51. Epub 2015/01/27. doi: 10.1016/j. jsat.2014.12.008.
19. Tran BX, Ohinmaa A, Nguyen LT. Quality of life profile and psychometric properties of the EQ-5D-5L in HIV/AIDS patients. Health Qual Life Outcomes. 2012; 10:132. Epub 2012/11/03. doi: 10.1186/1477- 7525-10-132
20. EQOL G. EQ-5D-5L User Guide: Basic information on how to use the EQ-5D-5L instrument. Rotterdam, The Netherlands2011.
21. Tran BX, Nguyen NP. Patient satisfaction with HIV/AIDS care and treatment in the decentralization of services delivery in Vietnam. PloS one. 2012; 7(10):e46680. doi: 10.1371/journal.pone.0046680
22. Hosmer DW Jr., L S, Sturdivant RX. Applied Logistic Regression. 3rd ed: Wiley; 2013.
23. Nguyen TT, Nguyen LT, Pham MD, Vu HH, Mulvey KP. Methadone maintenance therapy in Vietnam: an overview and scaling-up plan. Advances in preventive medicine. 2012; 2012:732484. Epub 2012/ 12/12. doi: 10.1155/2012/732484
24. Jardine M, Thi Nguyen VA, Khuat TH. Case study: Methadone maintenance treatment in Hanoi, Vietnam. Harm reduction journal. 2012; 9:26. Epub 2012/07/10. doi: 10.1186/1477-7517-9-26
25. Hogan B, Hershey L, Ritchey S. A case study using a patient satisfaction survey to improve the delivery and effectiveness of drug addiction treatment services: marketing implications and organizational impact. Health marketing quarterly. 2007; 24(1-2):93-106. Epub 2008/12/02. doi: 10.1080/ 07359680802125923.
26. Madden A, Lea T, Bath N, Winstock AR. Satisfaction guaranteed? What clients on methadone and buprenorphine think about their treatment. Drug Alcohol Rev. 2008; 27(6):671-8. Epub 2009/04/21. doi: 10.1080/09595230801935706.
27. Chow MY, Li M, Quine S. Client satisfaction and unmet needs assessment: evaluation of an HIV ambulatory health care facility in Sydney, Australia. Asia-Pacific journal of public health / Asia-Pacific Academic Consortium for Public Health. 2012; 24(2):406-14. doi: 10.1177/1010539510384843.
28. Olowookere SA, Fatiregun AA, Ladipo MM, Akenova YA. Reducing waiting time at a Nigerian HIV treatment clinic: opinions from and the satisfaction of people living with HIV/AIDS. Journal of the International Association of Physicians in AIDS Care (Chicago, Ill: 2002). 2012; 11(3):188-91. Epub 2011/04/
29. doi: 10.1177/1545109711402214.
30. Doubova SV, Perez-Cuevas R, Zepeda-Arias M, Flores-Hernandez S. Satisfaction of patients suffering from type 2 diabetes and/or hypertension with care offered in family medicine clinics in Mexico. Salud publica de Mexico. 2009; 51(3):231-9. Epub 2009/12/08.
31. Mitike G, Mekonnen A, Osman M. Satisfaction on outpatient services in hospitals of the Amhara Region. Ethiopian medical journal. 2002; 40(4):387-96. Epub 2003/02/25.
32. Crow R, Gage H, Hampson S, Hart J, Kimber A, Storey L, et al. The measurement of satisfaction with healthcare: implications for practice from a systematic review of the literature. Health technology assessment (Winchester, England). 2002; 6(32):1-244. Epub 2003/08/20.
33. Stein MD, Charuvastra A, Anderson B, Sobota M, Friedmanna PD. Alcohol and HIV risk taking among intravenous drug users. Addictive behaviors. 2002; 27(5):727-36. Epub 2002/08/31.
34. Donoghoe MC. Sex, HIV and the injecting drug user. British journal of addiction. 1992; 87(3):405-16. Epub 1992/03/01.
35. Tran BX, Ohinmaa A, Nguyen LT, Nguyen TA, Nguyen TH. Determinants of health-related quality of life in adults living with HIV in Vietnam. AIDS care. 2011; 23(10):1236-45. Epub 2011/06/30. doi: 10.1080/ 09540121.2011.555749.
36. Organization WH. Treatment of injecting drug users with HIV/AIDS: promoting access and optimizing service delivery. Geneva, Switzerland: 2006.
37. Samet JH, Stein MD, O'Connor PG. Models of Medical Care for HIV-infected Drug Users. Substance Abuse. 1995; 16(3):131-9. doi: 10.1080/08897079509444716
38. Herman M, Gourevitch MN. Integrating primary care and methadone maintenance treatment: implementation issues. Journal of addictive diseases. 1997; 16(1):91-102. doi: 10.1300/J069v16n01-06.
39. Tran B, Nguyen L, Ohinmaa A, Maher R, Nong V, Latkin CA. Longitudinal and cross sectional assessments of health utility in adults with HIV/AIDS: a systematic review and meta-analysis. BMC Health Serv Res. 2015; 15(1):7. Epub 2015/01/23. doi: 10.1186/s12913-014-0640-z
40. van Beek I. Case study: accessible primary health care-a foundation to improve health outcomes for people who inject drugs. The International journal on drug policy. 2007; 18(4):329-32. doi: 10.1016/j. drugpo.2006.11.005.
41. O'Connor PG, Molde S, Henry S, Shockcor WT, Schottenfeld RS. Human immunodeficiency virus infection in intravenous drug users: a model for primary care. The American journal of medicine. 1992; 93(4):382-6.
42. Selwyn PA, Budner NS, Wasserman WC, Arno PS. Utilization of on-site primary care services by HIVseropositive and seronegative drug users in a methadone maintenance program. Public Health Reports. 1993; 108(4):492-500. PMC1403415.
43. Umbricht-Schneiter A, Ginn DH, Pabst KM, Bigelow GE. Providing medical care to methadone clinic patients: referral vs on-site care. American Journal of Public Health. 1994; 84(2):207-10. PMC1615007.
44. Marchand K, Palis H, Peng D, Fikowski J, Harrison S, Spittal P, et al. The Role of Gender in Factors Associated With Addiction Treatment Satisfaction Among Long-Term Opioid Users. Journal of addiction medicine. 2015. Epub 2015/09/04. doi: 10.1097/ADM.0000000000000145.
45. Marchand KI, Oviedo-Joekes E, Guh D, Brissette S, Marsh DC, Schechter MT. Client satisfaction among participants in a randomized trial comparing oral methadone and injectable diacetylmorphine for long-term opioid-dependency. BMC Health Serv Res. 2011; 11:174. Epub 2011/07/28. doi: 10. 1186/1472-6963-11-174
46. Trujols J, Sinol N, de los Cobos JP. Methadone maintenance treatment: the need to distinguish between holding dose, dose adequacy, satisfaction with methadone as a medication, and satisfaction with treatment. Journal of clinical psychopharmacology. 2010; 30(1):95-6; author reply 6. Epub 2010/ 01/16. doi: 10.1097/JCP.0b013e3181c8b439.
47. Perez de Los Cobos J, Trujols J, Valderrama JC, Valero S, Puig T. Patient perspectives on methadone maintenance treatment in the Valencia Region: dose adjustment, participation in dosage regulation, and satisfaction with treatment. Drug Alcohol Depend. 2005; 79(3):405-12. Epub 2005/05/05. doi: 10. 1016/j.drugalcdep.2005.03.021